ZLAB
Zai Lab Launches its first Trust Report – Zai Lab Limited
Friday, October 14, 2022 BiopharmaWatch Research 1 min read Key Takeaway: Zai Lab Launches its first Trust Report – Zai Lab Limited
Price reaction · baseline $28.5 (2022-10-13 close) · hit after-hours · clean, no other ZLAB news in the window
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.2%
average across 15 past catalysts
Cash runway
~28 mo
Low dilution risk
Lead asset
ZL-1310
Phase 3 · Small-cell Lung Cancer
Full Press Release Details
Zai Lab Launches its first Trust Report – Zai Lab Limited.